生物标志物
生物标志物发现
医学
重性抑郁障碍
相关性(法律)
梅德林
生物信息学
精神科
重症监护医学
临床实习
精密医学
数据科学
钥匙(锁)
作者
Simon Vandekar,Panpan Zhang,Krishnan R. Patel,Angela Lee Jefferson,Frank E. Harrell
标识
DOI:10.1001/jamapsychiatry.2026.3852
摘要
Importance Biomarker discovery is a key research area in psychiatry, with the goals of identifying susceptibility to conditions, improving diagnostic accuracy, and predicting treatment response. Most biomarkers in psychiatry fail to be externally validated. Objective To discuss 5 key principles used in unreliable biomarker discovery and provide alternative strategies for rigorous internal validation of biomarkers that can improve rigor and replicability. Evidence Review Six articles were reviewed for biomarker discovery in major depressive disorder and their use of the 5 principles. Findings Well-documented unreliable practices have contributed to failed biomarker research. Modern methods are subject to the same unreliable principles. Conclusions and Relevance Rigorous biomarker discovery is rare and remains a challenge with complex data augmentation, synthetic data, and cross-validation strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI